539997
KWALITY
Start SIP
Invest Now
Start SIP in KWALITY
Performance
- Low
- ₹1,051
- High
- ₹1,073
- 52 Week Low
- ₹596
- 52 Week High
- ₹1,235
- Open Price₹1,073
- Previous Close₹1,073
- Volume4,950
- 50 DMA₹1,026.02
- 100 DMA₹993.85
- 200 DMA₹950.84
Investment Returns
- Over 1 Month + 4.05%
- Over 3 Month + 21.31%
- Over 6 Month -8.28%
- Over 1 Year + 24.5%
Smart Investing Starts Here Start SIP with Kwality Pharmaceuticals for Steady Growth!
Kwality Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 22.6
- PEG Ratio
- 0.3
- Market Cap Cr
- 1,108
- P/B Ratio
- 3.8
- Average True Range
- 62.59
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 35.28
- RSI
- 51.42
- MFI
- 59.87
Kwality Pharmaceuticals Financials
Kwality Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,068.00
-5.45
(-0.51%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹1,077.13
- 50 Day
- ₹1,026.02
- 100 Day
- ₹993.85
- 200 Day
- ₹950.84
Resistance and Support
1067.85
- R3 1,145.50
- R2 1,117.75
- R1 1,095.60
- S1 1,045.70
- S2 1,017.95
- S3 995.80
Kwality Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-11 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-01-31 | Quarterly Results | |
| 2024-10-30 | Quarterly Results |
Kwality Pharmaceuticals F&O
About Kwality Pharmaceuticals
- NSE Symbol
- KWALITY
- BSE Symbol
- 539997
- Managing Director
- Mr. Ramesh Arora
- ISIN
- INE552U01010
Similar Stocks to Kwality Pharmaceuticals
Kwality Pharmaceuticals FAQs
Kwality Pharmaceuticals share price is ₹1,068 As on 21 January, 2026 | 10:46
The Market Cap of Kwality Pharmaceuticals is ₹1108.2 Cr As on 21 January, 2026 | 10:46
The P/E ratio of Kwality Pharmaceuticals is 22.6 As on 21 January, 2026 | 10:46
The PB ratio of Kwality Pharmaceuticals is 3.8 As on 21 January, 2026 | 10:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.